You are currently viewing a new version of our website. To view the old version click .

Journal of Cardiovascular Development and Disease, Volume 10, Issue 7

July 2023 - 49 articles

Cover Story: Cardiac fibrosis contributes significantly to CVD, causing substantial global morbidity and mortality. This review comprehensively examines the cellular and molecular mechanisms of cardiac fibrosis, highlighting the need for novel therapeutic strategies. Striking a balance between inhibiting fibrosis and preserving tissue repair is challenging, as current off-label medications have limited efficacy and potential effects, prompting the exploration of alternatives. Bioactive compounds show promise in preclinical studies, targeting inflammation, fibroblast activation, collagen synthesis, and degradation. However, rigorous clinical trials are essential to validate their efficacy and safety. This review contributes to advancing anti-fibrotic therapy, offering hope for improved cardiac fibrosis management. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (49)

  • Review
  • Open Access
8 Citations
6,524 Views
29 Pages

Bioactive Compounds and Cardiac Fibrosis: Current Insight and Future Prospect

  • Abdul Majid,
  • Fasilat Oluwakemi Hassan,
  • Md Monirul Hoque,
  • Joy Olaoluwa Gbadegoye and
  • Djamel Lebeche

Cardiac fibrosis is a pathological condition characterized by excessive deposition of collagen and other extracellular matrix components in the heart. It is recognized as a major contributor to the development and progression of heart failure. Despit...

  • Article
  • Open Access
1 Citations
1,978 Views
16 Pages

Perioperative Application of Levosimendan Optimizes Postoperative Renal Function and Organ Perfusion in Patients with Severe Heart Failure

  • Vasileios Leivaditis,
  • Manfred Dahm,
  • Anastasia Papaporfyriou,
  • Michail Galanis,
  • Efstratios Koletsis,
  • Nikolaos Charokopos,
  • Benjamin Ehle,
  • Athanasios Papatriantafyllou,
  • Erich Haussmann and
  • Vladislav Kaplunov
  • + 1 author

Background: Renal dysfunction and impaired organ perfusion are common concerns following cardiac surgery. Levosimendan, a calcium sensitizer inotropic drug, is investigated in this study for its potential to improve postoperative renal function and o...

  • Article
  • Open Access
3 Citations
1,588 Views
9 Pages

Conventional vs. Sutureless Aortic Valve Bioprosthesis: Is Faster Better?

  • Ali Aljalloud,
  • Ajay Moza,
  • Jessica Paola Arias,
  • Matthias Menne,
  • Michael Becker and
  • Konstantina Spetsotaki

Purpose: The benefits of sutureless compared to conventional aortic valve prosthesis replacement remain controversial. Supposed advantages of sutureless aortic valve replacement include shortened cross-clamp and implantation time, as well as improved...

  • Article
  • Open Access
6 Citations
2,576 Views
18 Pages

Blood Immune Cell Alterations in Patients with Hypertensive Left Ventricular Hypertrophy and Heart Failure with Preserved Ejection Fraction

  • Artem Ovchinnikov,
  • Anastasiya Filatova,
  • Alexandra Potekhina,
  • Tatiana Arefieva,
  • Anna Gvozdeva,
  • Fail Ageev and
  • Evgeny Belyavskiy

(1) Background: Chronic inflammation and fibrosis are key players in cardiac remodeling associated with left ventricular hypertrophy (LVH) and heart failure with a preserved ejection fraction (HFpEF). Monocytes and T-helpers (Th) are involved in both...

  • Article
  • Open Access
8 Citations
2,733 Views
12 Pages

Background: Iron overload can accelerate the accumulation of lipid oxides and contribute to the progression of atherosclerosis. Ferritin heavy chain (FT-H) exhibits oxidase activity, which inhibits the toxicity of ferrous ions and reduces oxidative d...

  • Review
  • Open Access
3 Citations
2,061 Views
14 Pages

Effect of Aging on Intraventricular Kinetic Energy and Energy Dissipation

  • Donato Mele,
  • Riccardo Beccari and
  • Gianni Pedrizzetti

In recent years, analysis of kinetic energy (KE) and the rate of kinetic energy dissipation (KED) or energy loss (EL) within the cardiac chambers, obtained by cardiac imaging techniques, has gained increasing attention. Thus, there is a need to clari...

  • Review
  • Open Access
7 Citations
5,658 Views
13 Pages

Up to 20% of patients with ischemic stroke or transient ischemic attack have a prior history of known atrial fibrillation (AF). Additionally, unknown AF can be detected by different monitoring strategies in up to 23% of patients with cryptogenic or n...

  • Article
  • Open Access
2 Citations
2,607 Views
19 Pages

Methyltransferases regulate transcriptome dynamics during development and aging, as well as in disease. Various methyltransferases have been linked to heart disease, through disrupted expression and activity, and genetic variants associated with cong...

  • Review
  • Open Access
9 Citations
3,773 Views
17 Pages

Epigenetic marks regulate the transcriptomic landscape by facilitating the structural packing and unwinding of the genome, which is tightly folded inside the nucleus. Lysine-specific histone methylation is one such mark. It plays crucial roles during...

  • Review
  • Open Access
5 Citations
5,159 Views
20 Pages

An Overview of Sport Participation and Exercise Prescription in Mitral Valve Disease

  • Francesco Perone,
  • Mariangela Peruzzi,
  • Edoardo Conte,
  • Luigi Sciarra,
  • Giacomo Frati,
  • Elena Cavarretta and
  • Annachiara Pingitore

The incidence of heart valve disease (HVD) has been rising over the last few decades, mainly due to the increasing average age of the general population, and mitral valve (MV) disease is the second most prevalent HVD after calcific aortic stenosis, b...

of 5

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Cardiovasc. Dev. Dis. - ISSN 2308-3425Creative Common CC BY license